Filter your search
Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging
- $2,500.00 – $5,000.00The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Clinical laboratories are an essential part of the health industry. Kalorama Information estimates that approximately 80% of physicians’ diagnoses are a result of laboratory tests.he constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an ever […]February 1, 2010As the leader in diagnostic market research publishing, Kalorama Information publishes several informative diagnostic industry reports each year. This select diagnostic package is for those customers who know they will have diagnostic industry market research needs and wish to make a purchase now at a substantial savings off the standard global license price. includes 3 […]January 15, 2010$3,995.00 – $7,990.00As Kalorama Information’s lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, […]November 1, 2009$3,500.00 – $7,000.00The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets. Since our last round-up of the contrast media market, the economic […]November 1, 2009$995.00 – $1,990.00Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe trade but also in many other areas such as […]October 1, 2009$3,500.00 – $7,000.00This report analyzes the current and potential world market for medical MRI and ultrasound systems. This report generally reviews the nature and direction of research, as well as future markets for two key areas of imaging technology: Ultrasound and MRI. the report includes the following as part of its market coverage: Current Market Size […]August 1, 2009$995.00 – $1,900.00As Kalorama Information has examined the markets for year, we have seen the companies whose approaches have succeeded and those who have not been successful. A small pivot in strategy often may have made the difference. We have summed up this knowledge in What is Working in IVD: Successful Commercialization of New Products and Technologies […]July 1, 2009$250.00 – $1,600.00The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama’s lead analyst, Shara Rosen. Regardless […]May 1, 2009$250.00 – $3,395.00It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information’s lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen’s new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America […]May 1, 2009$1,500.00 – $9,990.00From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama’s leading diagnostic analyst, Shara Rosen. Far more than any […]April 1, 2009